ICICI Securities' Top Pick: Akums Drugs & Pharmaceuticals

ICICI Securities recommends a 'buy' for Akums Drugs & Pharmaceuticals, setting a target price of Rs 710. Analysts highlight the company's aim for profitable growth and its ability to maintain CDMO and overall EBITDA margins despite sub-par revenue growth in FY25. Efforts to curb losses in the API division and new export orders starting CY27 are expected to enhance operating leverage and margins in the future.

HDFC Securities' Recommendation: JSW Steel

HDFC Securities maintains a 'buy' rating on JSW Steel with a target price of Rs 1,080. The ramp-up of steel capacities at Vijayanagar and BPSL plants is boosting production and sales. Strong demand and improved flat prices, along with the expected implementation of safeguard duties on imports, are set to benefit steel prices.

Emkay Global Financial Services on Bajaj Finserv

Emkay Global Financial Services continues to recommend a 'buy' for Bajaj Finserv with a target price of Rs 2,000. The company's split from Allianz is seen as a positive move, with analysts believing it won't affect the fundamentals of Bajaj's life and general insurance businesses.

Yes Securities' New Coverage: Va Tech Wabag

Yes Securities has initiated coverage on Va Tech Wabag with a 'buy' recommendation and a target price of Rs 1,750. The company is well-positioned to capitalize on growth in India and the Middle East, with a substantial order book and expected margin improvements.

JM Financial's Pick: Baazar Style Retail

JM Financial has started coverage of Baazar Style Retail with a 'buy' rating and a target price of Rs 400. The company, operating under the Style Baazar brand, is a leading value fashion retailer in Eastern India, expected to improve profitability and shorten working capital days.